Cardiogenesis Settles Disagreement With Ex-CEO
The company’s filing with the U.S. Securities and Exchange Commission said that Cardiogenesis would pay Michael Quinn $550,000 in 72 equal bi-monthly payments.
Up to $75,000 of that amount will be paid to his attorney as fees. The agreement was reached Oct. 12.
Quinn will also be allowed to keep $689,008 in previously issued stock options with...
To view the full article, register now.